Cart
sales@molnova.com
TG-2-IN-1
CAS No. 135273-74-4
TG-2-IN-1( —— )
Catalog No. M35396 CAS No. 135273-74-4
TG-2-IN-1 is a potent transglutaminase-2 (TGM-2) inhibitor.TG-2-IN-1 is used in the study of cancer, neurological disorders, and immune system disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 77 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 201 | In Stock |
|
| 50MG | 290 | In Stock |
|
| 100MG | 431 | In Stock |
|
| 200MG | 631 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTG-2-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTG-2-IN-1 is a potent transglutaminase-2 (TGM-2) inhibitor.TG-2-IN-1 is used in the study of cancer, neurological disorders, and immune system disorders.
-
DescriptionTG-2-IN-1 is a potent transglutaminase-2 (TGM-2) inhibitor.TG-2-IN-1 is used in the study of cancer, neurological disorders, and immune system disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number135273-74-4
-
Formula Weight220.72
-
Molecular FormulaC8H13ClN2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[Cl-].O=C(C)CSC=1N(C=C[N+]1C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PKG inhibitor peptid...
PKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.
-
Lactisole
Lactisole is an inhibitor of the glucose-sensing receptor.
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
